Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

INVO Fertility (IVF) Enterprise Value (2016 - 2025)

INVO Fertility (IVF) has disclosed Enterprise Value for 15 consecutive years, with -$400000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Enterprise Value rose 20.0% to -$400000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$400000.0, a 20.0% increase, with the full-year FY2024 number at -$619520.0, down 166.55% from a year prior.
  • Enterprise Value was -$400000.0 for Q3 2025 at INVO Fertility, up from -$549181.0 in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$90135.0 in Q4 2022 to a low of -$8.4 million in Q1 2021.
  • A 5-year average of -$2.1 million and a median of -$840407.0 in 2025 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: plummeted 2306.64% in 2021, then surged 98.41% in 2022.
  • INVO Fertility's Enterprise Value stood at -$5.7 million in 2021, then soared by 98.41% to -$90135.0 in 2022, then crashed by 157.86% to -$232424.0 in 2023, then plummeted by 166.55% to -$619520.0 in 2024, then soared by 35.43% to -$400000.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Enterprise Value are -$400000.0 (Q3 2025), -$549181.0 (Q2 2025), and -$840407.0 (Q1 2025).